v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04383002 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : May 15, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : May 15, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Jennifer.Lister@uhn.ca |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-05-11 |
Recruitment status
Last imported at : April 12, 2022, 11 p.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: confirmed infection with covid-19 positive rt-pcr tracheal aspirate prior to treatment use of mechanical ventilation with or without ecmo male or female ages > 18 years < 14 days from symptom initiation to study enrolment and < 7 days from intubation to study enrolment |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
patients on other interventional clinical trials subjects diagnosed with congestive or unstable heart disease including heart failure, left ventricular dysfunction (lvef < 40 %) or myocardial damage, severe pulmonary hypertension and/or unstable hypertension subjects diagnosed with immunodeficiency hematology: patients with clinically significant anemia e.g. hemoglobin < 100 and thrombocytopenia e.g. platelets < 75 subjects with clinically significant history of, or active bleeding including active pulmonary or gastrointestinal bleeding hepatic function: patients with abnormal liver function defined as any two of the following alt >3x uln, ast >3x uln, total bilirubin < 1.5 x uln patient receiving drugs that have a contraindication with no e.g. use of a nitric oxide donor agent such as nitroglycerin or drugs known to increase methemoglobin such as lidocaine, prilocaine, benzocaine or dapsone at screening as relevant to the proposed study population pregnancy subjects with a known hypersensitivity to methylene blue, subjects with glucose-6-phosphate dehydrogenase (g6pd) deficiency known or suspected thalassemia, sickle cell disease, or other conditions associated with poor oxygen carrying capacity |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
University Health Network, Toronto |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Canada |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Critical disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
8: Critical disease at enrollment |
Total sample size
Last imported at : May 15, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
21 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
COVID-19 PCR status at completion of treatment (day 7) from tracheal aspirate |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 1 |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 890, "treatment_name": "Nitric oxide gas", "treatment_type": "Gas inhalation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |